J. David Leander - Publications

Affiliations: 
Skagit Neuropharm 

207 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Moskal JR, Burch R, Burgdorf JS, Kroes RA, Stanton PK, Disterhoft JF, Leander JD. GLYX-13, an NMDA receptor glycine site functional partial agonist enhances cognition and produces antidepressant effects without the psychotomimetic side effects of NMDA receptor antagonists. Expert Opinion On Investigational Drugs. 23: 243-54. PMID 24251380 DOI: 10.1517/13543784.2014.852536  1
2013 Burgdorf J, Zhang XL, Nicholson KL, Balster RL, Leander JD, Stanton PK, Gross AL, Kroes RA, Moskal JR. GLYX-13, a NMDA receptor glycine-site functional partial agonist, induces antidepressant-like effects without ketamine-like side effects. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 729-42. PMID 23303054 DOI: 10.1038/npp.2012.246  1
2003 Wolff MC, Leander JD. SR141716A, a cannabinoid CB1 receptor antagonist, improves memory in a delayed radial maze task. European Journal of Pharmacology. 477: 213-7. PMID 14522359 DOI: 10.1016/j.ejphar.2003.08.025  1
2003 Wolff MC, Leander JD. Comparison of the effects of antipsychotics on a delayed radial maze task in the rat. Psychopharmacology. 168: 410-6. PMID 12709778 DOI: 10.1007/s00213-003-1449-3  1
2002 Wolff MC, Leander JD. Selective serotonin reuptake inhibitors decrease impulsive behavior as measured by an adjusting delay procedure in the pigeon. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 27: 421-9. PMID 12225699 DOI: 10.1016/S0893-133X(02)00307-X  1
2001 Gleason SD, Lucaites VL, Shannon HE, Nelson DL, Leander JD. m-CPP hypolocomotion is selectively antagonized by compounds with high affinity for 5-HT(2C) receptors but not 5-HT(2A) or 5-HT(2B) receptors. Behavioural Pharmacology. 12: 613-20. PMID 11856898  1
2000 Wolff MC, Leander JD. A comparison of the behavioural effects of 5-HT2A and 5-HT2C receptor agonists in the pigeon. Behavioural Pharmacology. 11: 355-64. PMID 11103887  1
2000 Jackson-Guilford J, Leander JD, Nisenbaum LK. The effect of streptozotocin-induced diabetes on cell proliferation in the rat dentate gyrus. Neuroscience Letters. 293: 91-4. PMID 11027841 DOI: 10.1016/S0304-3940(00)01502-0  1
2000 Rasmussen K, Calligaro DO, Czachura JF, Dreshfield-Ahmad LJ, Evans DC, Hemrick-Luecke SK, Kallman MJ, Kendrick WT, Leander JD, Nelson DL, Overshiner CD, Wainscott DB, Wolff MC, Wong DT, Branchek TA, et al. The novel 5-Hydroxytryptamine(1A) antagonist LY426965: effects on nicotine withdrawal and interactions with fluoxetine. The Journal of Pharmacology and Experimental Therapeutics. 294: 688-700. PMID 10900249  1
1999 Gleason SD, Leander JD. Influence of light cycle on response to 5-HT1A ligands in punished responding in rats. Behavioural Pharmacology. 10: 785-91. PMID 10780294  1
1999 Wolff MC, Leander JD. The discriminative stimulus properties of LY233708, a selective serotonin reuptake inhibitor, in the pigeon. Psychopharmacology. 146: 275-9. PMID 10541727 DOI: 10.1007/s002130051117  1
1999 Anderson BA, Harn NK, Hansen MM, Harkness AR, Lodge D, Leander JD. Synthesis and anticonvulsant activity of 3-aryl-5H-2,3-benzodiazephine AMPA antagonists. Bioorganic & Medicinal Chemistry Letters. 9: 1953-6. PMID 10450961 DOI: 10.1016/S0960-894X(99)00315-7  1
1999 Benvenga MJ, Overshiner CD, Monn JA, Leander JD. Disinhibitory effects of LY354740, a new mGluR2 agonist, on behaviors suppressed by electric shock in rats and pigeons Drug Development Research. 47: 37-44. DOI: 10.1002/(SICI)1098-2299(199905)47:1<37::AID-DDR5>3.0.CO;2-S  1
1998 Ornstein PL, Arnold MB, Lunn WH, Heinz LJ, Leander JD, Lodge D, Schoepp DD. Heteroatom-substitution as a strategy for increasing the potency of competitive NMDA antagonists. Bioorganic & Medicinal Chemistry Letters. 8: 389-94. PMID 9871691 DOI: 10.1016/S0960-894X(98)00038-9  1
1998 Wolff MC, Leander JD. Selective serotonin reuptake inhibitors potentiate 8-OH-DPAT-induced stimulus control in the pigeon. European Journal of Pharmacology. 345: 35-9. PMID 9593591 DOI: 10.1016/S0014-2999(98)00052-1  1
1997 Wolff MC, Leander JD. Effects of a 5-HT1A receptor agonist on acute and delayed cyclophosphamide-induced vomiting. European Journal of Pharmacology. 340: 217-20. PMID 9537818 DOI: 10.1016/S0014-2999(97)01401-5  1
1997 Wolff MC, Leander JD. Differentiation of 5-HT1A receptor ligands by drug discrimination. European Journal of Pharmacology. 333: 113-22. PMID 9314023 DOI: 10.1016/S0014-2999(97)01125-4  1
1997 Moore NA, Leander JD, Benvenga MJ, Gleason SD, Shannon H. Behavioral pharmacology of olanzapine: a novel antipsychotic drug. The Journal of Clinical Psychiatry. 58: 37-44. PMID 9265915  1
1997 Wolff MC, Benvenga MJ, Calligaro DO, Fuller RW, Gidda JS, Hemrick-Luecke S, Lucot JB, Nelson DL, Overshiner CD, Leander JD. Pharmacological profile of LY301317, a potent and selective 5-HT(1A) agonist Drug Development Research. 40: 17-34. DOI: 10.1002/(SICI)1098-2299(199701)40:1<17::AID-DDR2>3.0.CO;2-W  1
1996 Benvenga MJ, Leander JD. Anticonflict effects of 5HT(1A) agonists in pigeons are dependent on the level of response suppression. Behavioural Pharmacology. 7: 540-550. PMID 11224451  1
1996 Ornstein PL, Arnold MB, Allen NK, Bleisch T, Borromeo PS, Lugar CW, Leander JD, Lodge D, Schoepp DD. Structure-activity studies of 6-substituted decahydroisoquinoline-3-carboxylic acid AMPA receptor antagonists. 2. Effects of distal acid bioisosteric substitution, absolute stereochemical preferences, and in vivo activity. Journal of Medicinal Chemistry. 39: 2232-44. PMID 8667366 DOI: 10.1021/jm950913h  1
1996 Ornstein PL, Arnold MB, Allen NK, Bleisch T, Borromeo PS, Lugar CW, Leander JD, Lodge D, Schoepp DD. Structure-activity studies of 6-(tetrazolylalkyl)-substituted decahydroisoquinoline-3-carboxylic acid AMPA receptor antagonists. 1. Effects of stereochemistry, chain length, and chain substitution. Journal of Medicinal Chemistry. 39: 2219-31. PMID 8667365 DOI: 10.1021/jm950912p  1
1995 Wolff MC, Leander JD. Comparison of the antiemetic effects of a 5-HT1A agonist, LY228729, and 5-HT3 antagonists in the pigeon. Pharmacology, Biochemistry, and Behavior. 52: 571-5. PMID 8545476 DOI: 10.1016/0091-3057(95)00142-J  1
1995 Schoepp DD, Lodge D, Bleakman D, Leander JD, Tizzano JP, Wright RA, Palmer AJ, Salhoff CR, Ornstein PL. In vitro and in vivo antagonism of AMPA receptor activation by (3S, 4aR, 6R, 8aR)-6-[2-(1(2)H-tetrazole-5-yl) ethyl] decahydroisoquinoline-3-carboxylic acid. Neuropharmacology. 34: 1159-68. PMID 8532186 DOI: 10.1016/0028-3908(95)00099-R  1
1995 Ornstein PL, Arnold MB, Allen NK, Leander JD, Tizzano JP, Lodge D, Schoepp DD. (3SR,4aRS,6SR,8aRS)-6-(1H-tetrazol-5-yl)decahydroisoquinoline-3-carboxylic acid, a novel, competitive, systemically active NMDA and AMPA receptor antagonist. Journal of Medicinal Chemistry. 38: 4885-90. PMID 8523401  1
1995 Benvenga MJ, Ornstein PL, Leander JD. Schedule-controlled behavioral effects of the selective 2-amino-3-(5-methyl-3-hydroxyisoxazol-4-yl)propanoic acid antagonist LY293558 in pigeons. The Journal of Pharmacology and Experimental Therapeutics. 275: 164-70. PMID 7562545  1
1995 Benvenga MJ, Leander JD. Olanzapine, an atypical antipsychotic, increases rates of punished responding in pigeons. Psychopharmacology. 119: 133-8. PMID 7544900 DOI: 10.1007/BF02246153  1
1995 Foreman MM, Fuller RW, Leander JD, Nelson DL, Calligaro DO, Lucaites VL, Wong DT, Zhang L, Barrett JE, Schaus JM. Pharmacological characterization of enantiomers of 8-thiomethyl-2-(di-n-propylamino)tetralin, potent and selective 5-HT(1A) receptor agonists Drug Development Research. 34: 66-85. DOI: 10.1002/ddr.430340110  1
1994 Kohn H, Sawhney KN, Robertson DW, Leander JD. Anticonvulsant properties of N-substituted alpha,alpha-diamino acid derivatives. Journal of Pharmaceutical Sciences. 83: 689-91. PMID 8071822 DOI: 10.1002/jps.2600830519  1
1994 Zimmerman DM, Gidda JS, Cantrell BE, Schoepp DD, Johnson BG, Leander JD. Discovery of a potent, peripherally selective trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidine opioid antagonist for the treatment of gastrointestinal motility disorders. Journal of Medicinal Chemistry. 37: 2262-5. PMID 8057274  1
1994 Wolff MC, Leander JD. Antiemetic effects of 5-HT1A agonists in the pigeon. Pharmacology, Biochemistry, and Behavior. 49: 385-91. PMID 7824554 DOI: 10.1016/0091-3057(94)90438-3  1
1994 Zimmerman DM, Gidda JS, Cantrell BE, Werner JA, Parli CJ, Franklin RB, Francis PC, Means JR, Pohland RC, Leander JD. LY246736 dihydrate. μ Opioid receptor antagonist Drugs of the Future. 19: 1078-1083.  1
1993 Mitch CH, Leander JD, Mendelsohn LG, Shaw WN, Wong DT, Cantrell BE, Johnson BG, Reel JK, Snoddy JD, Takemori AE. 3,4-Dimethyl-4-(3-hydroxyphenyl)piperidines: opioid antagonists with potent anorectant activity. Journal of Medicinal Chemistry. 36: 2842-50. PMID 8410999  1
1993 Zimmerman DM, Leander JD, Cantrell BE, Reel JK, Snoddy J, Mendelsohn LG, Johnson BG, Mitch CH. Structure-activity relationships of trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidine antagonists for mu- and kappa-opioid receptors. Journal of Medicinal Chemistry. 36: 2833-41. PMID 8410998  1
1993 Ornstein PL, Arnold MB, Augenstein NK, Lodge D, Leander JD, Schoepp DD. (3SR,4aRS,6RS,8aRS)-6-[2-(1H-tetrazol-5-yl)ethyl]decahydroisoquinoline-3 - carboxylic acid: a structurally novel, systemically active, competitive AMPA receptor antagonist. Journal of Medicinal Chemistry. 36: 2046-8. PMID 8393116  1
1993 Moore NA, Blackman A, Awere S, Leander JD. NMDA receptor antagonists inhibit catalepsy induced by either dopamine D1 or D2 receptor antagonists. European Journal of Pharmacology. 237: 1-7. PMID 8359205 DOI: 10.1016/0014-2999(93)90085-V  1
1993 Foreman MM, Fuller RW, Leander JD, Benvenga MJ, Wong DT, Nelson DL, Calligaro DO, Swanson SP, Lucot JB, Flaugh ME. Preclinical studies on LY228729: a potent and selective serotonin1A agonist. The Journal of Pharmacology and Experimental Therapeutics. 267: 58-71. PMID 8229788  1
1993 Ornstein PL, Arnold MB, Augenstein NK, Deeter JB, Leander JD, Lodge D, Calligaro DO, Schoepp DD. Unusual stereochemical preferences of decahydroisoquinoline-3-cargoxylic acid competitive NMDA antagonists Bioorganic and Medicinal Chemistry Letters. 3: 2067-2072. DOI: 10.1016/S0960-894X(01)81017-9  1
1993 Monn JA, Valli MJ, 1 RA, Schoepp DD, Leander JD, Lodge D. Synthesis and pharmacological characterization of l-trans-4-tetrazolylproline (ly300020): A novel systemically-active ampa receptor agonist Bioorganic and Medicinal Chemistry Letters. 3: 95-98. DOI: 10.1016/S0960-894X(00)80099-2  1
1993 Ornstein PL, Arnold MB, Evrard D, Leander JD, Lodge D, Schoepp DD. Tetrazole amino acids as competitive NMDA antagonists Bioorganic and Medicinal Chemistry Letters. 3: 43-48. DOI: 10.1016/S0960-894X(00)80089-X  1
1992 Leander JD. Interaction of the anticonvulsant ameltolide with standard anticonvulsants. Epilepsia. 33: 705-11. PMID 1628588 DOI: 10.1111/j.1528-1157.1992.tb02351.x  1
1992 Leander JD, Parli CJ, Potts B, Lodge D. Relation of plasma and brain concentrations of the anticonvulsant ameltolide to its pharmacologic effects. Epilepsia. 33: 696-704. PMID 1628587 DOI: 10.1111/j.1528-1157.1992.tb02350.x  1
1992 Leander JD. Fluoxetine, a selective serotonin-uptake inhibitor, enhances the anticonvulsant effects of phenytoin, carbamazepine, and ameltolide (LY201116). Epilepsia. 33: 573-6. PMID 1534297 DOI: 10.1111/j.1528-1157.1992.tb01712.x  1
1992 Engelhardt JA, Parli CJ, Kovach PM, Shoufler JR, Emmerson JL, Leander JD. Subchronic toxicity, metabolism, and pharmacokinetics of the aminobenzamide anticonvulsant ameltolide (LY201116) in rhesus monkeys. Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology. 19: 197-201. PMID 1516775 DOI: 10.1016/0272-0590(92)90151-7  1
1992 McQuaid LA, Leander JD, Mendelsohn LG, Smith EC, Lawson RR, Mason NR. Inhibition of [3H]-MK801 binding and protection against NMDA-induced lethality in mice by a series of imipramine analogs. Research Communications in Chemical Pathology and Pharmacology. 77: 171-8. PMID 1439188  1
1992 Ornstein PL, Schoepp DD, Arnold MB, Augenstein NK, Lodge D, Millar JD, Chambers J, Campbell J, Paschal JW, Zimmerman DM. 6-substituted decahydroisoquinoline-3-carboxylic acids as potent and selective conformationally constrained NMDA receptor antagonists. Journal of Medicinal Chemistry. 35: 3547-60. PMID 1404235  1
1992 Ornstein PL, Schoepp DD, Arnold MB, Jones ND, Deeter JB, Lodge D, Leander JD. NMDA antagonist activity of (+/-)-(2SR,4RS)-4-(1H-tetrazol-5-ylmethyl)piperidine-2-carboxylic acid resides with the (-)-2R,4S-isomer. Journal of Medicinal Chemistry. 35: 3111-5. PMID 1387167  1
1992 Engelhardt JA, Parli CJ, Kovach PM, Shoufler JR, Emmerson JL, Leander JD. Subchronic toxicity, metabolism, and pharmacokinetics of the aminobenzamide anticonvulsant ameltolide (LY2O1 116) in rhesus monkeys Toxicological Sciences. 19: 197-201. DOI: 10.1093/toxsci/19.2.197  1
1992 Zimmerman DM, Schoepp DD, Leander JD, Ornstein PL. The discovery and characterization of the competitive NMDA antagonists LY274614, LY233536 and LY233053 Molecular Neuropharmacology. 2: 77-81.  1
1992 Leander JD. Comparative behavioural pharmacology of competitive and non-competitive NMDA antagonists Molecular Neuropharmacology. 2: 93-96.  1
1991 Robertson DW, Beedle EE, Krushinski JH, Lawson RR, Parli CJ, Potts B, Leander JD. Synthesis and pharmacological evaluation of a major metabolite of ameltolide, a potent anticonvulsant. Journal of Medicinal Chemistry. 34: 1253-7. PMID 2016702  1
1991 Kohn H, Sawhney KN, LeGall P, Robertson DW, Leander JD. Preparation and anticonvulsant activity of a series of functionalized alpha-heteroatom-substituted amino acids. Journal of Medicinal Chemistry. 34: 2444-52. PMID 1875341  1
1991 Schoepp DD, Ornstein PL, Salhoff CR, Leander JD. Neuroprotectant effects of LY274614, a structurally novel systemically active competitive NMDA receptor antagonist. Journal of Neural Transmission. General Section. 85: 131-43. PMID 1834088 DOI: 10.1007/BF01244705  1
1991 Ornstein PL, Schoepp DD, Arnold MB, Leander JD, Lodge D, Paschal JW, Elzey T. 4-(Tetrazolylalkyl)piperidine-2-carboxylic acids. Potent and selective N-methyl-D-aspartic acid receptor antagonists with a short duration of action. Journal of Medicinal Chemistry. 34: 90-7. PMID 1825117  1
1991 Schoepp DD, Smith CL, Lodge D, Millar JD, Leander JD, Sacaan AI, Lunn WH. D,L-(tetrazol-5-yl) glycine: a novel and highly potent NMDA receptor agonist. European Journal of Pharmacology. 203: 237-43. PMID 1686860 DOI: 10.1016/0014-2999(91)90719-7  1
1991 Shaw WN, Mitch CH, Leander JD, Mendelsohn LG, Zimmerman DM. The effect of the opioid antagonist LY255582 on body weight of the obese Zucker rat. International Journal of Obesity. 15: 387-95. PMID 1653188  1
1990 Shaw WN, Mitch CH, Leander JD, Zimmerman DM. Effect of phenylpiperidine opioid antagonists on food consumption and weight gain of the obese Zucker rat. The Journal of Pharmacology and Experimental Therapeutics. 253: 85-9. PMID 2329525  1
1990 Kohn H, Sawhney KN, LeGall P, Conley JD, Robertson DW, Leander JD. Preparation and anticonvulsant activity of a series of functionalized alpha-aromatic and alpha-heteroaromatic amino acids. Journal of Medicinal Chemistry. 33: 919-26. PMID 2308141  1
1990 Zimmerman DM, Leander JD. Opioid antagonists: structure activity relationships. Nida Research Monograph. 96: 50-60. PMID 2172827  1
1990 Zimmerman DM, Leander JD. Selective opioid receptor agonists and antagonists: research tools and potential therapeutic agents. Journal of Medicinal Chemistry. 33: 895-902. PMID 2155322  1
1990 Schmidhammer H, Leander JD, Mayer-Valkanover K, Nussbaumer C, Schmidt C, Schoepp DD, Schratz A, Walla-Kugler M. 5-Methylated naloxone, naltrexone, oxymorphone, and their 14-O-methyl ethers. Progress in Clinical and Biological Research. 328: 41-4. PMID 2154800  1
1990 Ornstein PL, Schoepp DD, Leander JD, Wong T, Zimmerman DM, Lodge D. LY233053: a structurally novel, potent and selective competitive N-methyl-D-aspartate receptor antagonist. Progress in Clinical and Biological Research. 361: 429-33. PMID 2149764  1
1990 Schoepp DD, Ornstein PL, Leander JD, Lodge D, Salhoff CR, Zeman S, Zimmerman DM. Pharmacological characterization of LY233053: a structurally novel tetrazole-substituted competitive N-methyl-D-aspartic acid antagonist with a short duration of action. The Journal of Pharmacology and Experimental Therapeutics. 255: 1301-8. PMID 2148188  1
1990 Willetts J, Balster RL, Leander JD. The behavioral pharmacology of NMDA receptor antagonists. Trends in Pharmacological Sciences. 11: 423-8. PMID 2147794 DOI: 10.1016/0165-6147(90)90150-7  1
1990 Robertson DW, Beedle EE, Lawson RR, Leander JD. Benzamide anticonvulsants: a comparison of the pharmacology of LY201116 and two congeners with alternate para substituents European Journal of Pharmacology. 183: 601-602. DOI: 10.1016/0014-2999(90)93521-Q  1
1990 Clark CR, Robertson DW, Leander JD. Ameltolide Drugs of the Future. 15: 983-985.  1
1989 Leander JD. Evaluation of dextromethorphan and carbetapentane as anticonvulsants and N-methyl-D-aspartic acid antagonists in mice. Epilepsy Research. 4: 28-33. PMID 2666123 DOI: 10.1016/0920-1211(89)90055-7  1
1989 Leander JD. Tricyclic antidepressants block N-methyl-D-aspartic acid-induced lethality in mice. British Journal of Pharmacology. 96: 256-8. PMID 2647204  1
1989 Ornstein PL, Schaus JM, Chambers JW, Huser DL, Leander JD, Wong DT, Paschal JW, Jones ND, Deeter JB. Synthesis and pharmacology of a series of 3- and 4-(phosphonoalkyl)pyridine- and -piperidine-2-carboxylic acids. Potent N-methyl-D-aspartate receptor antagonists. Journal of Medicinal Chemistry. 32: 827-33. PMID 2539478  1
1989 Schmidhammer H, Leander JD, Mayer-Valkanover K, Nussbaumer C, Schmidt C, Schoepp DD, Schratz A, Walla-Kugler M. 5-methyl analogs of naloxone, naltrexone and oxymorphone | 5-METHYLANALOGA DES NALOXONS, NALTREXONS UND OXYMORPHONS Scientia Pharmaceutica. 57: 209.  1
1988 Leander JD, Lawson RR, Robertson DW. Anticonvulsant effects of a novel aminobenzamide (LY201116) in mice. Neuropharmacology. 27: 623-8. PMID 3419545 DOI: 10.1016/0028-3908(88)90184-0  1
1988 Leander JD, Robertson DW, Clark CR, Lawson RR, Rathbun RC. Pharmacological effects of enantiomers of 4-amino-N-(alpha-methylbenzyl)benzamide, a chemically novel anticonvulsant. Epilepsia. 29: 83-90. PMID 3338426  1
1988 Leander JD, Lawson RR, Ornstein PL, Zimmerman DM. N-methyl-D-aspartic acid-induced lethality in mice: selective antagonism by phencyclidine-like drugs. Brain Research. 448: 115-20. PMID 3292008 DOI: 10.1016/0006-8993(88)91107-9  1
1988 Robertson DW, Krushinski JH, Fuller RW, Leander JD. Absolute configurations and pharmacological activities of the optical isomers of fluoxetine, a selective serotonin-uptake inhibitor. Journal of Medicinal Chemistry. 31: 1412-7. PMID 3260286  1
1988 Robertson DW, Lawson RR, Rathbun RC, Leander JD. Pharmacology of LY201409, a potent benzamide anticonvulsant. Epilepsia. 29: 760-9. PMID 3191892  1
1988 Parli CJ, Evenson E, Potts BD, Beedle E, Lawson R, Robertson DW, Leander JD. Metabolism of the prodrug DEGA (N-(2,6-dimethylphenyl)-4-[[(diethylamino)acetyl]amino]benzamide) to the potent anticonvulsant LY201116 in mice. Effect of bis-(p-nitrophenyl)phosphate. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 16: 707-11. PMID 2906594  1
1988 Leander JD. Buprenorphine is a potent kappa-opioid receptor antagonist in pigeons and mice. European Journal of Pharmacology. 151: 457-61. PMID 2850923 DOI: 10.1016/0014-2999(88)90543-2  1
1988 Leander JD, Rathbun RC, Zimmerman DM. Anticonvulsant effects of phencyclidine-like drugs: relation to N-methyl-D-aspartic acid antagonism. Brain Research. 454: 368-72. PMID 2841999 DOI: 10.1016/0006-8993(88)90839-6  1
1988 Leander JD, Gesellchen PD, Mendelsohn LG. Opioid antinociceptive effects of delta-receptor antagonists. Pharmacology, Biochemistry, and Behavior. 29: 351-5. PMID 2834753 DOI: 10.1016/0091-3057(88)90168-2  1
1988 Zimmerman DM, Cantrell BE, Swartzendruber JK, Jones ND, Mendelsohn LG, Leander JD, Nickander RC. Synthesis and analgesic properties of N-substituted trans-4a-aryldecahydroisoquinolines. Journal of Medicinal Chemistry. 31: 555-60. PMID 2831363  1
1988 Schmidhammer H, Deeter JB, Jones ND, Leander JD, Schoepp DD, Swartzendruber JK. Synthesis, structure elucidation, and pharmacological evaluation of 5-methyl-oxymorphone (= 4,5α-epoxy-3,14-dihydroxy-5,17-dimethylmorphinan-6-one) Helvetica Chimica Acta. 71: 1801-1804.  1
1987 Leander JD. Bremazocine-induced urination in rats of different sizes. Research Communications in Chemical Pathology and Pharmacology. 57: 141-4. PMID 3671877  1
1987 Robertson DW, Beedle EE, Lawson R, Leander JD. Imidazole anticonvulsants: structure-activity relationships of [(biphenylyloxy)alkyl]imidazoles. Journal of Medicinal Chemistry. 30: 939-43. PMID 3572983  1
1987 Leander JD. Fluoxetine suppresses palatability-induced ingestion. Psychopharmacology. 91: 285-7. PMID 3104951 DOI: 10.1007/BF00518178  1
1987 Leander JD. Cross-tolerance to metkephamid (LY127623) produced by morphine solution ingestion by mice. Alcohol and Drug Research. 7: 321-5. PMID 3040022  1
1987 Leander JD, Hart JC, Zerbe RL. Kappa agonist-induced diuresis: evidence for stereoselectivity, strain differences, independence of hydration variables and a result of decreased plasma vasopressin levels. The Journal of Pharmacology and Experimental Therapeutics. 242: 33-9. PMID 3039112  1
1987 Leander JD. Delineation of mu-antagonist, partial kappa agonist and non-opioid agonist activity of cyclazocine using urinary output of rats. Pharmacology, Biochemistry, and Behavior. 26: 705-7. PMID 3037567 DOI: 10.1016/0091-3057(87)90600-9  1
1987 Zimmerman DM, Leander JD, Reel JK, Hynes MD. Use of beta-funaltrexamine to determine mu opioid receptor involvement in the analgesic activity of various opioid ligands. The Journal of Pharmacology and Experimental Therapeutics. 241: 374-8. PMID 3033213  1
1987 Leander JD. Effects of specific D-1 and D-2 dopamine agonists (LY141865 and SKF-38393) and pergolide on urinary output of rats. Archives Internationales De Pharmacodynamie Et De ThéRapie. 289: 290-5. PMID 2962555  1
1987 Leander JD. Effects of phencyclidine-like drugs on urine output of normally hydrated rats Research Communications in Substances of Abuse. 8: 39-42.  1
1986 Robertson DW, Krushinski JH, Beedle EE, Leander JD, Wong DT, Rathbun RC. Structure-activity relationships of (arylalkyl)imidazole anticonvulsants: comparison of the (fluorenylalkyl)imidazoles with nafimidone and denzimol. Journal of Medicinal Chemistry. 29: 1577-86. PMID 3746810  1
1986 Leander JD. Peripheral action of serotonin as a model of depression. Biological Psychiatry. 21: 842-4. PMID 3488080 DOI: 10.1016/0006-3223(86)90250-7  1
1986 Leander JD, Gesellchen PD, Mendelsohn LG. Comparison of two penicillamine-containing enkephalins: mu, not delta, activity produces analgesia. Neuropeptides. 8: 119-25. PMID 3020472 DOI: 10.1016/0143-4179(86)90038-7  1
1986 Leander JD, Wood CR, Zimmeman DM, Dykstra LA. Phencyclidine-type catalepsy in the pigeon: An update on Chen's work Drug Development Research. 7: 75-85.  1
1985 Leander JD, Zerbe RL, Hart JC. Diuresis and suppression of vasopressin by kappa opioids: comparison with mu and delta opioids and clonidine. The Journal of Pharmacology and Experimental Therapeutics. 234: 463-9. PMID 2991502  1
1985 Zimmerman DM, Smits SE, Hynes MD, Cantrell BE, Leander JD, Mendelsohn LG, Nickander R. Picenadol. Drug and Alcohol Dependence. 14: 381-401. PMID 2986931 DOI: 10.1016/0376-8716(85)90069-9  1
1985 Zimmerman DM, Rathbun RC, Leander JD. Anticonvulsant effects of various phencyclidine-like compounds in mice Federation Proceedings. 44: No. 1832.  1
1985 Leander JD. Further analysis of the effects of dopamine antagonists (antipsychotics) on schedule-controlled behavior of the pigeon Federation Proceedings. 44: No. 2806.  1
1984 Carter RB, Leander JD. Comparison of the effects of naloxone and picrotoxin on schedule-controlled responding in the pigeon: possible GABA-antagonistic effects of naloxone. The Journal of Pharmacology and Experimental Therapeutics. 230: 40-6. PMID 6747830  1
1984 Leander JD, Carter RB. Effects of norepinephrine and serotonin uptake inhibitors on the schedule-controlled behavior of the pigeon. Pharmacology, Biochemistry, and Behavior. 20: 391-5. PMID 6608736 DOI: 10.1016/0091-3057(84)90277-6  1
1984 Leander JD. Kappa-opioid diuretic effects of tifluadom, a benzodiazepine opioid agonist. The Journal of Pharmacy and Pharmacology. 36: 555-6. PMID 6148404  1
1984 Fuller RW, Leander JD. Elevation of serum corticosterone in rats by bremazocine, a kappa-opioid agonist. The Journal of Pharmacy and Pharmacology. 36: 345-6. PMID 6145778  1
1984 Leander JD. Effects of full and partial kappa agonists and mu agonists on urine output of normally hydrated rats. Neuropeptides. 5: 283-6. PMID 6099514 DOI: 10.1016/0143-4179(84)90083-0  1
1984 Mendelsohn LG, Kerchner GA, Kalra V, Zimmerman DM, Leander JD. Phencyclidine receptors in rat brain cortex. Biochemical Pharmacology. 33: 3529-35. PMID 6095851 DOI: 10.1016/0006-2952(84)90133-3  1
1984 Leander JD. Kappa opioid agonists and antagonists: effects on drinking and urinary output. Appetite. 5: 7-14. PMID 6091543  1
1984 Hynes MD, Leander JD, Frederickson RCA. Evaluation of THIP in standard tests for analgesic activity: Occurrence of antinociception and hyperalgesia Drug Development Research. 4: 405-419.  1
1984 Leander JD, Hart JC, Rell JK, Zimmerman DM. β-Funaltrexamine (β-FNA) blocks mu-opioid agonists on shocktitration in the squirrel monkey Federation Proceedings. 43: no. 3980.  1
1984 Leander JD, Zimmerman DM. Antagonism of bremazocine-induced urination as a test for kappa-opioid receptor antagonists within the phenylpiperidine series Drug Development Research. 4: 421-427.  1
1983 Leander JD. Opioid agonist and antagonist behavioural effects of buprenorphine. British Journal of Pharmacology. 78: 607-15. PMID 6850163  1
1983 Witkin JM, Leander JD, Dykstra LA. Modification of behavioral effects of morphine, meperidine and normeperidine by naloxone and by morphine tolerance. The Journal of Pharmacology and Experimental Therapeutics. 225: 275-83. PMID 6842391  1
1983 Leander JD, Zimmerman DM. Effects of picenadol and its agonist and antagonist isomers on schedule-controlled behavior. The Journal of Pharmacology and Experimental Therapeutics. 227: 671-5. PMID 6655562  1
1983 Leander JD, Hynes MD. Opioid antagonists and drinking: evidence of kappa-receptor involvement. European Journal of Pharmacology. 87: 481-4. PMID 6303802 DOI: 10.1016/0014-2999(83)90089-4  1
1983 Leander JD. A kappa opioid effect: increased urination in the rat. The Journal of Pharmacology and Experimental Therapeutics. 224: 89-94. PMID 6294284  1
1983 Leander JD. Further study of kappa opioids on increased urination. The Journal of Pharmacology and Experimental Therapeutics. 227: 35-41. PMID 6137557  1
1983 Leander JD. Interactions of clozapine, thioridazine, and mezilamine with oxotremorine on schedule-controlled responding. Psychopharmacology. 80: 29-30. PMID 6135236 DOI: 10.1007/BF00427489  1
1983 Leander JD. Evidence that nalorphine, butorphanol and oxilorphan are partial agonists at a kappa-opioid receptor. European Journal of Pharmacology. 86: 467-70. PMID 6131829 DOI: 10.1016/0014-2999(83)90198-X  1
1983 Zimmerman DM, Leander JD. Antagonism of bremazocine's diuretic effects by novel phenylpiperidine opioid antagonists Federation Proceedings. 42: No. 1979.  1
1983 Leander JD, Zimmerman DM. Picenadol, a mixed opioid agonist/antagonist without κ opioid agonist activity in the rat urination test Drug Development Research. 3: 483-488.  1
1983 Leander JD. Effects of punishment-attenuating drugs on deprivation-induced drinking: Implications for conflict procedures Drug Development Research. 3: 184-191.  1
1982 Leander JD. Effects of piribedil on schedule-controlled responding of the pigeon. Pharmacology, Biochemistry, and Behavior. 17: 995-1000. PMID 7178209 DOI: 10.1016/0091-3057(82)90484-1  1
1982 Leander JD, Wood CR. Metkephamid effects on operant behavior. Peptides. 3: 771-3. PMID 7177922 DOI: 10.1016/0196-9781(82)90013-4  0.52
1982 Witkin JM, Leander JD. Effects of orally-administered ethanol and tertiary-butanol on fixed-ratio responding of rats. Substance and Alcohol Actions/Misuse. 3: 275-9. PMID 7167864  1
1982 Witkin JM, Leander JD. Effects of the appetite stimulant chlordimeform on food and water consumption of rats: comparison with chlordiazepoxide. The Journal of Pharmacology and Experimental Therapeutics. 223: 130-4. PMID 7120114  1
1982 Leander JD, Carter RB. Attenuation of normeperidine's suppressing effect on schedule-controlled behavior. European Journal of Pharmacology. 81: 107-10. PMID 7117363 DOI: 10.1016/0014-2999(82)90606-9  1
1982 Anders E, Dietz DD, Bagnell CR, Gaynor J, Krigman MR, Ross DW, Leander JD, Mushak P. Morphological, pharmacokinetic, and hematological studies of lead-exposed pigeons. Environmental Research. 28: 344-63. PMID 7117222 DOI: 10.1016/0013-9351(82)90134-7  1
1982 Leander JD. Interaction of diazepam with meperidine or normeperidine on analgesia and lethality. Pharmacology, Biochemistry, and Behavior. 16: 1005-7. PMID 7111343 DOI: 10.1016/0091-3057(82)90061-2  1
1982 Leander JD, McCleary PE. Opioid and nonopioid behavioral effects of methadone isomers. The Journal of Pharmacology and Experimental Therapeutics. 220: 592-6. PMID 7062269  1
1982 McCleary P, Leander JD. Meperidine-induced hypothermia in the rat. Neuropharmacology. 21: 1337-41. PMID 6984142 DOI: 10.1016/0028-3908(82)90143-5  1
1982 Carter RB, Leander JD. Discriminative stimulus properties of naloxone. Psychopharmacology. 77: 305-8. PMID 6291084 DOI: 10.1007/BF00432760  1
1982 Leander JD, Hart JC, Lochner MA, Hynes MD, Zimmerman DM. Novel phenylpiperidine opioid antagonists and partial agonists: effects on fluid consumption. European Journal of Pharmacology. 81: 185-92. PMID 6288403 DOI: 10.1016/0014-2999(82)90436-8  1
1982 Leander JD. Effects of profadol on operant behavior in the pigeon. Pharmacology, Biochemistry, and Behavior. 16: 487-90. PMID 6210915 DOI: 10.1016/0091-3057(82)90457-9  1
1982 Leander JD. Comparison of phencyclidine, etoxadrol and dexoxadrol in the pigeon. Substance and Alcohol Actions/Misuse. 3: 197-203. PMID 6132451  1
1982 Leander JD. Effects of ketazocine, ethylketazocine and phenazocine on schedule-controlled behavior: antagonism by naloxone. Neuropharmacology. 21: 923-8. PMID 6128693 DOI: 10.1016/0028-3908(82)90085-5  1
1982 Leander JD. Opioid agonist and antagonist behavioral effects of buprenorphine Federation Proceedings. 41: No. 6114.  1
1982 Carter RB, Leander JD, Dykstra LA. Contribution of normeperidine to the analgesic effects of meperidine Federation Proceedings. 41: No. 6107.  1
1982 Witkin JM, Leander JD, Dykstra LA. Modification of behavioral effects of morphine, meperidine, and normeperidine by naloxone and morphine tolerance Federation Proceedings. 41: No. 5551.  1
1982 Leander JD. Body weight as a determinant of avoidance behavior Research Communications in Psychology, Psychiatry and Behavior. 7: 347-360.  1
1981 Leander JD. Drug effects on multiple and alternating mixed-schedule performance. The Journal of Pharmacology and Experimental Therapeutics. 218: 728-33. PMID 7264956  1
1981 Leander JD. Antagonism by methysergide of the effects of L-5-hydroxytryptophan and quipazine on schedule-controlled responding. Neuropharmacology. 20: 1141-3. PMID 6976522 DOI: 10.1016/0028-3908(81)90054-X  1
1981 McCleary PE, Leander JD. Clonidine analgesia and suppression of operant responding: dissociation of mechanism. European Journal of Pharmacology. 69: 63-9. PMID 6970665 DOI: 10.1016/0014-2999(81)90602-6  1
1981 Leander JD. SKF-525A on schedule-controlled responding: not antagonized by naloxone. Psychopharmacology. 75: 94-5. PMID 6795667 DOI: 10.1007/BF00433510  1
1981 Leander JD. Antagonism of oxotremorine-induced behavioral suppression by antimuscarinic drugs. Psychopharmacology. 75: 5-8. PMID 6795660 DOI: 10.1007/BF00433492  1
1981 Leander JD. Effects of tetrabenazine and phenylpiperidine analgesics during daily clorgyline treatment. Psychopharmacology. 74: 221-5. PMID 6115448  1
1981 Jones LA, Beaver RW, Schmoeger TL, Ort JF, Leander JD. Isolation, identification, and synthesis of compounds cosynthesized in the preparation of phencyclidine Journal of Organic Chemistry. 46: 3330-3333.  1
1981 Carter RB, Leander JD. Comparison of serotonergic agonists as inducers of taste aversions Federation Proceedings. 40: 177.  1
1981 Leander JD, Ort JF, Jones LA. Pharmacological effects of 3 co-synthetics of phencyclidine Research Communications in Substances of Abuse. 2: 173-185.  1
1981 Witkin JM, Leander JD. Effects of chlordimeform, a formamidine pesticide, on food and water consumption and punished behavior of rats: Comparison with chlordiazepoxide Federation Proceedings. 40: No. 2562.  1
1981 MacPhail RC, Leander JD. Chlordimeform effects on schedule-controlled behavior in rats Neurobehavioral Toxicology and Teratology. 3: 19-26.  1
1980 McMillan DE, Leander JD, Dudley KH. Effects of drugs on behavior in pigeons tolerant to delta 9-tetrahydrocannabinol. The Journal of Pharmacology and Experimental Therapeutics. 212: 85-90. PMID 7351628  1
1980 Carter RB, Leander JD. Evidence for a peripheral effect of sertonin or metabolites in 5-hydroxytryptophan-induced hypothermia. Neuropharmacology. 19: 777-84. PMID 6968413 DOI: 10.1016/0028-3908(80)90070-2  1
1980 Carter RB, Harden TK, Leander JD. Effect of meperidine and analogues on 3H-quinuclidinyl benzilate (3H-QNB) binding in rat brain Pharmacologist. 22: No.797.  1
1980 MacPhail RC, Leander JD. Flavor aversions induced by chlordimeform Neurobehavioral Toxicology and Teratology. 2: 363-365.  1
1980 Leander JD, MacPhail RC. Effect of chlordimeform (A formamidine pesticide) on schedule-controlled responding of pigeons Neurobehavioral Toxicology and Teratology. 2: 315-321.  1
1980 Carter RB, Leander JD. Chronic low-level lead exposure: Effects on schedule-controlled responding revealed by drug challenge Neurobehavioral Toxicology and Teratology. 2: 345-353.  1
1980 Leander JD, Gau BA. Flavor aversions rapidly produced by inorganic lead and triethyl tin Neurotoxicology. 1: 635-642.  1
1980 Leander JD. Low-level lead exposure: Attenuation of d-amphetamine's rate-increasing effects Neurotoxicology. 1: 551-559.  1
1980 MacPhail RC, Leander JD. Effects of chlordimeform on the schedule-controlled performance of rats Federation Proceedings. 39: 4400.  1
1979 Lucot JB, McMillan DE, Leander JD. The behavioral effects of d-amphetamine alone and in combination with acute and chronic morphine treatments in rats. The Journal of Pharmacology and Experimental Therapeutics. 210: 158-65. PMID 572418  1
1979 Lucot JB, McMillan DE, Leander JD. The behavioral effects of chlorpromazine alone and in combination with different morphine treatments in rats. The Journal of Pharmacology and Experimental Therapeutics. 208: 67-72. PMID 569698  1
1979 Leander JD. Attenuating the rate-decreasing effects of phenylpiperidine analgesics by pentobarbital. Psychopharmacology. 63: 81-8. PMID 112627 DOI: 10.1007/BF00426926  1
1979 Leander JD. Effects of propoxyphene, ethoheptazine, and azabicyclane on schedule-controlled responding: attenuation by pentobarbital but not naloxone. Psychopharmacology. 66: 19-22. PMID 44372 DOI: 10.1007/BF00431983  1
1979 McCleary P, Leander JD. Meperidine-induced hypothermia in the rat. A non-narcotic effect mediated by mechanisms other than inhibition of serotonin re-uptake Federation Proceedings. 38: No. 3299.  1
1979 Carter RB, Leander JD. Evidence for a peripheral effect of serotonin or metabolites in 5-hydroxytryptophan (5-HTP)-induced hypothermia Federation Proceedings. 38: No. 2430.  1
1979 Leander JD. Meperidine as a drug cue in pigeons: Not a narcotic effect Federation Proceedings. 38: No. 3344.  1
1978 Leander JD. An analysis of normeperidine's contribution to the rate-decreasing effects of meperidine. Pharmacology, Biochemistry, and Behavior. 9: 191-4. PMID 714969 DOI: 10.1016/0091-3057(78)90163-6  1
1978 McMillan DE, Leander JD. Chronic chlordiazepoxide and pentobarbital interactions on punished and unpunished behavior. The Journal of Pharmacology and Experimental Therapeutics. 207: 515-20. PMID 712634  1
1978 McMillan DE, Leander JD. Food, water and ethanol consumption by rats under a fixed-interval schedule of food presentation. Drug and Alcohol Dependence. 3: 227-34. PMID 688856 DOI: 10.1016/0376-8716(78)90076-5  1
1978 Leander JD, McMillan DE. Mazindol effects on schedule-controlled responding of the pigeon. European Journal of Pharmacology. 48: 11-7. PMID 639839 DOI: 10.1016/0014-2999(78)90039-0  1
1978 Leander JD. Comparing the effects of anileridine, alphaprodine and fentanyl on schedule-controlled responding by pigeons. The Journal of Pharmacology and Experimental Therapeutics. 206: 624-35. PMID 581295  1
1978 Carter RB, Dykstra LA, Leander JD, Appel JB. Role of peripheral mechanisms in the behavioral effects of 5-hydroxytryptophan. Pharmacology, Biochemistry, and Behavior. 9: 249-53. PMID 309609 DOI: 10.1016/0091-3057(78)90172-7  1
1978 Barthalmus GT, Leander JD, McMillan DE. Combined effects of ethanol and diazepam on performance and acquisition of serial position sequences by pigeons. Psychopharmacology. 59: 101-2. PMID 100807 DOI: 10.1007/BF00428039  1
1978 Dykstra LA, Leander JD. Electric shock titration: effects of meperidine, anileridine and alphaprodine. Pharmacology, Biochemistry, and Behavior. 8: 387-9. PMID 97674 DOI: 10.1016/0091-3057(78)90074-6  1
1978 Leander JD, Batten J, Hargis GW. Pehidine interaction with clorgyline, pargyline, or 5-hydroxytryptophan: lack of enhanced pethidine lethality or hyperpyrexia in mice. The Journal of Pharmacy and Pharmacology. 30: 396-8. PMID 26781  1
1978 Carter RB, Leander JD. Attenuation of the effects of naloxone on schedule-controlled responding of pigeons by pentobarbital Pharmacologist. 20: 408.  1
1978 Carter RB, Dykstra LA, Leander JD, Appel JB. 5-Hydroxytryptophan (5-HTP) on operant responding: evidence for a peripheral effect Federation Proceedings. 37: No. 3734.  1
1978 Leander JD. Comparing the effects of anileridine, alphaprodine, and fentanyl on schedule-controlled responding Federation Proceedings. 37: No.2919.  1
1978 Leander JD. Attenuating the rate-decreasing effects of meperidine-like analgesics with pentobarbital Pharmacologist. 20: 407.  1
1977 Leander JD, Lucot JB. Toxic interactions of stimulants, narcotics and narcotic antagonists. Research Communications in Chemical Pathology and Pharmacology. 17: 255-64. PMID 877411  1
1977 Leander JD, McMillan DE. Meperidine effects on schedule-controlled responding. The Journal of Pharmacology and Experimental Therapeutics. 201: 434-43. PMID 859106  1
1977 Barthalmus GT, Leander JD, McMillan DE, Mushak P, Krigman MR. Chronic effects of lead on schedule-controlled pigeon behavior. Toxicology and Applied Pharmacology. 42: 271-84. PMID 595007 DOI: 10.1016/0041-008X(77)90004-7  1
1977 Leander JD, McMillan DE, Barlow TS. Chronic mercuric chloride: Behavioral effects in pigeons. Environmental Research. 14: 424-35. PMID 590232 DOI: 10.1016/0013-9351(77)90050-0  1
1977 McMillan DE, Leander JD. Effects of chlordiazepoxide on punished and unpunished responding before and during chlordiazepoxide drinking Pharmacologist. 19: No. 574.  1
1977 Harto NE, Howard JL, Leander JD. Effects of d-amphetamine on a multiple fixed-ratio, fixed-interval schedule of food reinforcement in the cat Pharmacologist. 19: No. 562.  1
1977 Barthalmus GT, Leander JD, McMillan DE. Effects of chronic lead administration on schedule controlled behavior of pigeons Environmental Health Perspectives. 290.  1
1976 Leander JD, Mcmillan DE, Ellis FW. Ethanol and isopropanol effects on schedule-controlled responding. Psychopharmacologia. 47: 157-64. PMID 1273211 DOI: 10.1007/BF00735815  1
1976 Leander JD. Effects of promazine, chlorpromazine, d-amphetamine, and pentobarbital on treadle pressing by pigeons under a signalled shock-postponement schedule. Journal of the Experimental Analysis of Behavior. 26: 361-8. PMID 1003071 DOI: 10.1901/jeab.1976.26-361  1
1976 Mcmillan DE, Leander JD. Interactions between naloxone and narcotic analgesics under three schedules that induce polydipsia. Pharmacology, Biochemistry, and Behavior. 5: 195-200. PMID 996051 DOI: 10.1016/0091-3057(76)90036-8  1
1976 McMillan DE, Leander JD, Wilson TW, Wallace SC, Fix T, Redding S, Turk RT. Oral ingestion of narcotic analgesics by rats. The Journal of Pharmacology and Experimental Therapeutics. 196: 269-79. PMID 943520  1
1976 Leander JD. Effects of d-amphetamine, pentobarbital, chlorpromazine and promazine on electric shock postponement responding by the pigeon. The Journal of Pharmacology and Experimental Therapeutics. 198: 4-11. PMID 933011  1
1976 Leander JD. Effects of naloxone and pentazocine on continuous shock-postponement responding by the pigeon. Psychopharmacology. 50: 211-3. PMID 826964 DOI: 10.1007/BF00430495  1
1976 McMillan DE, Leander JD, Ellis FW, Lucot JB, Frye GD. Characteristics of ethanol drinking patterns under schedule-induced polydipsia. Psychopharmacology. 49: 49-55. PMID 822447 DOI: 10.1007/BF00427470  1
1976 McMillan DE, Leander JD. Schedule-induced oral self administration of etonitazene. Pharmacology, Biochemistry, and Behavior. 4: 137-41. PMID 4820 DOI: 10.1016/0091-3057(76)90005-8  1
1976 Leander JD. Meperidine effects on schedule controlled responding: lack of methadone cross tolerance and antagonism by narcotic antagonists Pharmacologist. 18: no. 355.  1
1976 Leander JD. Chronic mercuric chloride in pigeons: effects on schedule controlled responding Federation Proceedings. 35: No.1643.  1
1976 McMillan DE, Leander JD. Changes in the effects of pentobarbital and chlordiazepoxide on punished and unpunished behaviour as function of chronic pentobarbital drinking Pharmacologist. 18: No.668.  1
1976 Lucot JB, McMillan DE, Leander JD. Behavioral interactions between d amphetamine and chronic morphine consumption in the rat Pharmacologist. 18: No. 165.  1
1975 Leander JD, McMillan DE, Harris LS. Effects of narcotic agonists and antagonists on schedule-induced water and morphine ingestion. The Journal of Pharmacology and Experimental Therapeutics. 195: 271-8. PMID 1237618  1
1975 Leander JD, McMillan DE, Harris LS. Schedule-induced oral narcotic self-administration: acute and chronic effects. The Journal of Pharmacology and Experimental Therapeutics. 195: 279-87. PMID 1185597  1
1975 McMillan DE, Leander JD. Drugs and punished responding. V. Effects of drugs on responding suppressed by response-dependent and response-independent electric shock. Archives Internationales De Pharmacodynamie Et De ThéRapie. 213: 22-7. PMID 1156015  1
1975 Leander JD. Rate-dependent Effects of drugs. II. effects of some major tranquilizers on multiple fixed-ratio, fixed-interval schedule performance. The Journal of Pharmacology and Experimental Therapeutics. 193: 689-700. PMID 238028  1
1975 Leander JD, McMillan DE. Schedule-induced narcotic ingestion. Pharmacological Reviews. 27: 475-87. PMID 4822  1
1975 Leander JD. Behavioral effects of meperidine alone and in combination with naloxone Federation Proceedings. 34: No. 3213.  1
1975 McMillan DE, Leander JD, Lucot JB. Some effects of parathion on the schdule controlled behavior of the pigeon Pharmacologist. 17: No.159.  1
1974 Leander JD, McMillan DE. Rate-dependent effects of drugs. I. Comparisons of d-amphetamine, pentobarbital and chlorpromazine on multiple and mixed schedules. The Journal of Pharmacology and Experimental Therapeutics. 188: 726-39. PMID 4816335  1
1974 McMillan DE, Leander JD, Ellis FW. Consumption of ethanol and water under schedule induced polydipsia (SIP) Pharmacologist. 16: No. 639.  1
1974 Leander JD, McMillan DE, Ellis FW. Ethanol and isopropanol: comparison of behavioral effects Pharmacologist. 16: No. 640.  1
1971 Means LW, Leander JD, Isaacson RL. The effects of hippocampectomy on alternation behavior and response of novelty. Physiology & Behavior. 6: 17-22. PMID 5125451 DOI: 10.1016/0031-9384(71)90006-0  1
Show low-probability matches.